Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

CD19-CAR-T in B-cell Malignancies Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03952923
Recruitment Status : Recruiting
First Posted : May 16, 2019
Last Update Posted : November 14, 2019
China Immunotech Co., Ltd.
Avalon GloboCare Corp.
Information provided by (Responsible Party):
Hebei Yanda Ludaopei Hospital

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 1, 2021
Estimated Study Completion Date : October 31, 2021